A House committee on Wednesday advanced legislation that would extend Medicare telehealth flexibilities and a home hospital ...

A long-running race to develop a gene therapy for the most common cause of age-related blindness is heating up. On Wednesday, ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

Some drugmakers' submission of multiple "use codes" to expand patent claims appears to be delaying the arrival of lower-cost ...

The process for translating clinical trial results into action for young women in Africa has been left to our imaginations, ...

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

DEHP, a cancer-causing chemical, is widely present in IV devices used to treat cancer. California is poised to take action, ...

In the months after the retraction, Chris Ferguson, a psychologist at Stetson University and an editor at a different ...

The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients ...

Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and ...

Hims & Hers, one of the largest publicly traded telehealth companies in the country, has supercharged its business in the last several months by offering compounded versions of the patented weight ...

It’s unclear what kind of system Vance was envisioning, and Trump’s platform doesn’t actually mention the ACA at all. The confusion has provided Democrats with a new line of attack, STAT’s John ...